RARA CRAFT DATABASE for FDA Medical Devices
510(k)K201039

FDA DEVICE FACTS

HepaFat-AI

Resonance Health Analysis Services Pty Ltd

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

AI/ML
DECISION DATEDecember 7, 2020PRODUCT CODELNHCLINICAL AREARadiology

Indications for use

HepaFat-AI is indicated to:

• Assess the volumetric liver fat fraction, proton density fat fraction and steatosis grade in individuals with confirmed or suspected fatty liver disease; When interpreted by a trained physician, the results can be used to

• monitor liver fat content in patients undergoing weight loss management and can be used to

• aid in the assessment and screening of living donors for liver transplant.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026